Mastering Translational Medicine in Preclinical Drug Research

Date(s) - 13 Sep 2012
8:00 AM - 9:00 AM



Webinar: Mastering Translational Medicine in Preclinical Drug Research Hosted by: Ryan McBride, Editor, FierceBiotechDate: September 13th, 2012  |  Time: 11am ET / 8am PT  |  Duration: 1 hour

To give drug candidates the best odds of success in later human trials, biopharma companies have emphasized translational medicine and approaches of intelligently ushering scientific discoveries from the lab to the clinic.Join FierceBiotech and three preclinical experts on September 13thfor a live webinar to discuss translational medicine in the preclinical phase.To Register, click here

The webinar will cover biomarker discovery, predictive modeling and other strategies and experiments for optimizing decision-making prior to human studies. Learn about how biopharma leaders have crafted proof-of-biology experiments to advance programs seamlessly from animal to human studies and use insights from preclinical experiments to design clinical trials.


Michael Gilman, Senior Vice President of Early Stage Programs, Biogen Idec.
Arthur A. Levin, Ph.D.,  Executive Vice President of Research and Development, miRagen Therapeutics
Tom Turi, Vice President, Science & Technology, Discovery & Translational Services, Covance

Leave a Reply